RNU7-116P

Across TCGA pan-cancer cohorts, RNU7-116P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU7-116P data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher RNU7-116P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-116P expression acts as an unfavorable survival marker, although some lineages such as UCS show a favorable association.

PAAD, COAD, and DLBC are the cancer types where RNU7-116P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.060	0.641	<.001	72	view →
COAD	OS	Tertile	III,IV	0.056	0.793	<.001	72	view →
DLBC	DFS	Tertile	IV	0.120	0.683	.001	36	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
BRCA	DFS	Tertile	III,IV	0.373	0.796	.040	18	view →
UCS	DFS	Tertile	All	1.000	0.223	.044	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU7-116P–PAAD (OS)

Open the PAAD breakdown →